Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is NASDAQ OMX Group, Inc. (NDAQ) Cheap?

Page 1 of 2

Recently, a famous private equity fund, Carlyle Group LP (NASDAQ:CG), entered discussions with NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) to discuss taking the exchange company private. However, the deal fell apart because the two parties couldn’t agree with each other on the buyout price. Since the middle of 2012, NASDAQ’s share price has experienced quite a sweet rise, from $22 per share to more than $31 per share. Is NASDAQ a good investment opportunity at its current price? Let’s see.

NASDAQ OMX Group, Inc. (NASDAQ:NDAQ)Business Snapshot

NASDAQ, founded in 1971, is a global exchange group operating several exchanges, including the NASDAQ Stock Market in the US. It has three main business segments: Market Services, Issuer Services, and Market Technology. The majority of its net revenue (less transaction rebates, brokerage, clearance and exchange fees), $1.1 billion, or 66.4%, was generated from the Market Services segment. The Issuer Services ranked second, generating $375 million in revenue, while the net revenue of the Market Technology segment was $184 million in 2012.

Consistent and Growing Cash Flow

What I like about NASDAQ is the consistent and growing cash flow that it has generated in the past 10 years. Since 2002, the operating cash flow has grown from $157 million to nearly $670 million. The free cash flow has also followed the same trend, increasing from $72 million in 2002 to $581 million in 2011. Indeed, I personally think that was what Carlyle was looking for: a growing and consistent cash generator. In addition, NASDAQ seems to have quite a strong balance sheet with a reasonable amount of leverage. As of December 2012, it had $5.2 billion in total equity, nearly $500 million in cash, and $1.93 billion in long-term debt. However, what worries me is the huge goodwill and intangible assets that NASDAQ carried on its balance sheet. At the end of 2012, it had $5.34 billion in goodwill and $1.65 billion in intangible assets. With the huge goodwill and intangibles, NASDAQ is quite vulnerable to write-downs, which would negatively affect its short-term earnings result. Since 2007, NASDAQ has returned a huge amount of cash to shareholders in the form of share buybacks. The amount of treasury stock increased from $8 million in 2007 to more than $1 billion in 2012.

Relatively Undervalued Compared to Peers

At the current trading price of $31 per share, NASDAQ’s total market cap is $5.12 billion. The market is valuing NASDAQ at only 7.28x EV/EBITDA. This valuation could be considered the cheapest compared to its two peers CME Group Inc (NASDAQ:CME) and NYSE Euronext (NYSE:NYX). CME is trading at $58.50 per share, with a total market cap of $19.4 billion. The market is valuing CME at 10.57x EV/EBITDA. NYSE Euronext seems to be the most expensive, with 11.2x EV multiples. NYSE Euronext is trading at nearly $37.60 per share, with a total market cap of $9.13 billion. Among the three, CME seemed to be the most profitable, with a 58% operating margin. NASDAQ ranked second with a 25% operating margin, while the LTM operating margin of NYSE Euronext was 22%.  NASDAQ is paying investors the lowest dividend yield at 1.7% while the dividend yields of CME and NYSE Euronext are 3.1% and 3.2%, respectively.  If NASDAQ were trading at a comparable level to its peers, at around 10x EV/EBITDA, NASDAQ’s enterprise value would be $8.75 billion. Thus, NASDAQ would be worth around $7.5 billion on the market, or around $45.50 per share.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!